The RESILIENT-Extend trial is the first major study of thrombectomy in the late time window conducted outside first-world countries. Francisco Mont'alverne explains the trial's design and key findings. He discusses the impact of conducting this study in Latin America compared to first-world countries, highlighting the challenges and implications for stroke care in the region.